Results 141 to 150 of about 338,947 (383)

Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis†

open access: yesBritish Journal of Dermatology, 2019
Moderate‐to‐severe atopic dermatitis (AD) is a chronic disease characterized by intense, persistent and debilitating itch, resulting in sleep deprivation, signs of anxiety and depression, impaired quality of life and reduced productivity.
Gil Yosipovitch   +16 more
semanticscholar   +1 more source

Brain processing of contagious itch in patients with atopic dermatitis [PDF]

open access: yes, 2017
Several studies show that itch and scratching cannot only be induced by pruritogens like histamine or cowhage, but also by the presentation of certain (audio-) visual stimuli like pictures on crawling insects or videos showing other people scratching ...
Apkarian   +44 more
core   +3 more sources

Genital Psoriasis: Shining Light on This Hidden Disease

open access: yesJEADV Clinical Practice, EarlyView.
Psoriasis occurring on skin of the genital and perigenital regions has specific diagnostic and treatment requirements due to the sensitivity and private nature of these areas. A multidisciplinary group of experts in the management of genital psoriasis, the Genital Psoriasis Wellness Consortium, convened to discuss the impact of genital psoriasis on ...
Jennifer Cather   +19 more
wiley   +1 more source

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo‐controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)

open access: yesBritish Journal of Dermatology, 2018
Atopic dermatitis is a chronic inflammatory skin disease that may require systemic therapy. Ciclosporin A (CsA) is a widely used, potent immunosuppressant but it is not effective in all patients with atopic dermatitis, and side‐effects limit its use ...
M. Bruin-Weller   +14 more
semanticscholar   +1 more source

The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis

open access: yesClinical and Translational Allergy, 2023
Lotte S. Spekhorst   +11 more
doaj   +1 more source

Emerging Topical and Systemic JAK Inhibitors in Dermatology [PDF]

open access: yes, 2019
Accumulating data on cellular and molecular pathways help to develop novel therapeutic strategies in skin inflammation and autoimmunity. Examples are psoriasis and atopic dermatitis, two clinically and immunologically well-defined disorders.
Ghoreschi, Kamran   +2 more
core   +1 more source

A Survey on Methotrexate Prescribing and Monitoring Practices in Ireland

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Methotrexate, originally an anti‐neoplastic agent, is now extensively used at lower doses in dermatology and rheumatology for chronic inflammatory conditions. While its safety is supported by routine blood monitoring, there remains variability in recommended monitoring frequency, folic acid supplementation, liver function testing ...
Ji Fung Yong   +7 more
wiley   +1 more source

Novel insights into atopic dermatitis.

open access: yesJournal of Allergy and Clinical Immunology, 2022
Charles F. Schuler   +4 more
semanticscholar   +1 more source

Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis

open access: yesJAMA dermatology, 2019
Key Points Question What is the efficacy and safety of dupilumab monotherapy in adolescents with moderate to severe inadequately controlled atopic dermatitis?
E. Simpson   +26 more
semanticscholar   +1 more source

Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial

open access: yesNature Network Boston, 2021
T. Nakatsuji   +16 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy